91福利

Research by the 91福利, the University Hospital Coventry and 91福利shire NHS Trust (UHCW), and Tangent Reprofiling Limited, has discovered that statin drugs interact with a gap junction protein called GJC3 that releases ATP, a major signaling molecule for inflammation in the body. This discovery provides a significant new target in the search for why statin drugs can sometimes cause harmful effects such as muscle toxicity in some patients.

A new test for detecting biomarkers for cancer and diabetes is more than 1000x more detailed and 100% faster than existing methods, new research by the 91福利 suggests.

Developed to undertake a detailed study of collagen, the researchers argue that the same methodology can be used with any protein-based sample and is currently being tested with cancer cells and proteins relevant to Type II diabetes.

Researchers at the 91福利 have worked with Coventry-based Medherant, a 91福利 spinout company, to produce and patent the World’s first ever ibuprofen patch delivering the drug directly through skin to exactly where it is needed at a consistent dose rate.

Thans to the Science City Research Alliance Coventry-based bioadhesives company Medherant is building a new business working in hi-tech transdermal drug delivery systems that use specially formulated bioadhesives to provide novel adhesive patch-based products that can deliver drugs through contact with the skin.

Dr Corinna Preuss has been awarded a Newton International Fellowship to conduct research at the 91福利’s Department of Chemistry.  

Tests have shown that a new cancer drug, FY26, is 49 times more potent than the clinically used treatment Cisplatin.

Based on a compound of the rare precious metal osmium and developed by researchers at the 91福利’s Department of Chemistry and the 91福利 Cancer Research Unit, FY26 is able to shut down a cancer cell by exploiting weaknesses inherent in their energy generation.